Methyl 2-Chloroacrylate | CAS 80-63-7 - Request Quote
Methyl 2-Chloroacrylate
| SZ CAT No: | SZ-L033065 |
| CAS No | 80-63-7 |
| Mol.F. | C4H5ClO2 |
| Mol.Wt. |
120.5 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Methyl 2-Chloroacrylate is chemically Methyl 2-chloroacrylate. Methyl 2-Chloroacrylate is supplied with detailed characterization data compliant with regulatory guideline. Methyl 2-Chloroacrylate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Lacosamide.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 80-63-7
Purchase 80-63-7
Order 80-63-7
Enquire 80-63-7
price of 80-63-7
80-63-7 Supplier
80-63-7 Manufacturer
80-63-7 Exporter
buy high quality Methyl 2-Chloroacrylate
Purchase Methyl 2-Chloroacrylate
Methyl 2-Chloroacrylate suppliers
Methyl 2-Chloroacrylate manufacturers
Methyl 2-Chloroacrylate price
Order Methyl 2-Chloroacrylate
Enquire Methyl 2-Chloroacrylate
Methyl 2-Chloroacrylate cost
Methyl 2-Chloroacrylate Supplier
Methyl 2-Chloroacrylate Distributor
Methyl 2-Chloroacrylate for Method Validation
Lacosamide Reference Standard
Methyl 2-Chloroacrylate for ANDA Filing
Methyl 2-Chloroacrylate for Forced Degradation Studies
Methyl 2-Chloroacrylate Identification Standards
Methyl 2-Chloroacrylate for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.